Early-Onset Neonatal Sepsis Clinical Trial
Official title:
Prediction of Early-Onset Neonatal Sepsis (EONS) in Pregnant Women With Preterm Premature Rupture of Membranes (PPROM) by Vaginal Microbiome Analysis - a Pilot Study
An EONS occurred in nearly 14-22 % of the preterm infant of pregnant women with PPROM. To this day no risk prediction is established. The main aim of this pilot study is generating primary data with a focus on the vaginal microbiome to set-up a prospective, multi-centre trial investigating the role of the vaginal microbiome for future EONS risk prediction. The planned PEONS pilot trial is subdivided in three Work packages: 1. Recruitment, sample collection and routine clinical diagnostics 2. Microbiome analysis by 16S rRNA 3. Microbiome/ Metagenome analysis by "Nanopore" (proof-of-principle) and will enroll women with a PPROM event hospitalized between 22+0 and 34+0 weeks of gestation and neonates with signs of EONS (Subgroup 1) and without signs of EONS (Subgroup 2).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06076200 -
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations
|
||
Completed |
NCT03694613 -
Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants
|
N/A | |
Recruiting |
NCT03997266 -
NICU Antibiotics and Outcomes Trial
|
Phase 4 | |
Recruiting |
NCT05329701 -
Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns.
|
Phase 4 | |
Not yet recruiting |
NCT06377397 -
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates
|
Phase 3 | |
Recruiting |
NCT06197269 -
Efficacy And Safety Of Short Course Antibiotic Therapy In Preterm Neonates With Early Onset Sepsis
|
N/A | |
Not yet recruiting |
NCT06100614 -
Presepsin to Safely Reduce Antibiotics in Preterm Infants
|
N/A | |
Not yet recruiting |
NCT05796115 -
PROcalcitonin and Presepsin-guided Decision for Antibiotic Prophylaxis of EOS
|
N/A |